| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_180fee1c3d9f8e42132723d1f89416b7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-526
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2809 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2021-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bea4ff15830963958f01de1b49172060
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0af60eae67e3d319d82db18316e3fc34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ca2237e0793cc9751fe58e7e8c5893d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd5b27b525f3358b0403937300fa6c77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cbad1f688e5720a5037901ba4e42ac7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abb2afe4fcfec7c82475001c226dd024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_881d1abb14f3acf07cc590c7d9755166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2656034a5fd6d4408f3174eeb5dc852b |
| publicationDate |
2022-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022122973-A1 |
| titleOfInvention |
Antibodies that bind gamma-delta t cell receptors |
| abstract |
The present invention relates to antibodies capable of binding a human Vy9V&2T cell receptor. The invention further relates to pharmaceutical compositions comprising the antibodies of the invention and to uses of the antibodies of the invention for medical treatment. |
| priorityDate |
2020-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |